United States · FDA National Drug Code directory
AKYNZEO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69639-101_c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1
- Product NDC
- 69639-101
- Form
- CAPSULE
- Composition / generic term
- Netupitant and Palonosetron
- Labeler
- Helsinn Therapeutics (U.S.), Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20141013
- Source listing expiry
- 20271231
Source-listed ingredients
- NETUPITANT — 300 mg/1
- PALONOSETRON — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (69639-101-01) / 1 CAPSULE in 1 BLISTER PACK · 69639-101-01
- 2 BLISTER PACK in 1 CARTON (69639-101-04) / 2 CAPSULE in 1 BLISTER PACK · 69639-101-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →